Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder

Patient characteristics a N (%) or mean (±SD) b
SCORPIO (n = 1906) ARIES (n = 1270) CAPRICORN (n = 1251) Pooled trials (n = 4427)
Age 59.1 (±12.4) 60.2 (±13.4) 59.1 (±13.0) 59.4 (±12.9)
Female 1372 (72.0%) 950 (74.8%) 857 (68.5%) 3179 (71.8%)
BMI 27.8 (±4.9) 30.2 (±7.0) 29.4 (±6.4) 28.9 (±6.1)
Geographical region
Western Europe 1906 (54.2%) 0 (0.0%) 359 (28.7%) 1392 (31.4%)
Eastern Europe 873 (45.8%) 0 (0.0%) 222 (17.8%) 1095 (24.7%)
USA 0 (0.0%) 127 (10.0%) 584 (46.7%) 1727 (39.0%)
Canada 0 (0.0%) 1143 (90.0%) 86 (6.9%) 213 (4.8%)
Previously treated with antimuscarinics 946 (49.6%) 714 (56.2%) 642 (51.3%) 2302 (52.0%)
Baseline mean number of micturitions per 24 h 11.6 (±2.9) 11.7 (±3.4) 11.6 (±3.1) 11.6 (±3.1)
Baseline mean number of incontinence episodes per 24 h 1.7 (±2.4) 2.1 (±2.7) 2.3 (±2.3) 1.8 (±2.5)
  1. aBMI: Body mass index; USA: United States of America.
  2. bSD: Standard deviation.